The TOP ‐ GERD Trial: Comparative Efficacy of Tegoprazan Versus Pantoprazole in the Treatment of Erosive Oesophagitis in a Non‐Asian Population
Open Access
- 3 October 2026
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
Abstract
Background: Potassium‐competitive acid blockers provide rapid and sustained acid suppression, but tegoprazan has not been studied in non‐Asian populations. Aim: To compare the efficacy and safety of tegoprazan 50 mg once daily with pantoprazole 40 mg once daily for healing erosive oesophagitis and improving reflux symptoms. Methods: In this multicentre, randomized, double‐blind, active‐controlled trial, Mexican adults with Los Angeles grade B–D erosive oesophagitis received tegoprazan or pantoprazole for 4 weeks. The primary outcome was superior endoscopic healing at week 4. Secondary outcomes included early symptom response, complete symptom resolution, changes in symptom severity, health‐related quality of life, and adverse events. Results: Seventy participants were randomized and 64 completed treatments. In the intention‐to‐treat population, endoscopic healing occurred in 88.9% receiving tegoprazan and 79.4% receiving pantoprazole ( p = 0.33). In the per‐protocol population, healing occurred in 100% and 84.4%, respectively ( p = 0.053). Among participants with Los Angeles grade C or D oesophagitis, per‐protocol healing rates were 100% with tegoprazan and 68.8% with pantoprazole ( p = 0.04). During the first treatment week, at least 50% symptom improvement occurred in 84.4% and 31.3%, respectively ( p < 0.001), and complete symptom resolution was more frequent with tegoprazan from day 1. Symptom severity and health‐related quality of life improved in both groups. Adverse events were infrequent, mild, and unrelated to treatment. Conclusions: There was a nonsignificant 9.5% difference in the primary intention‐to‐treat 4‐week healing endpoint between tegoprazan and pantoprazole. Tegoprazan provided faster symptom improvement, while the per‐protocol findings and the higher healing rate observed in the exploratory severe oesophagitis subgroup were encouraging and warrant further investigation. (ClinicalTrials.gov Identifier: NCT06991348).Keywords
This publication has 17 references indexed in Scilit:
- Validation of Dominant Symptom Intensity as a Patient-Reported Outcome Measure in the Evaluation of Esophageal SymptomsJournal of Clinical Gastroenterology, 2026
- Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trialChinese Medical Journal, 2024
- Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2022
- AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert ReviewClinical Gastroenterology and Hepatology, 2022
- Review article: potassium‐competitive acid blockers for the treatment of acid‐related disordersAlimentary Pharmacology & Therapeutics, 2021
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor DosingClinical Pharmacology & Therapeutics, 2020
- Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ‐12420), a novel potassium‐competitive acid blocker, in healthy male subjectsAlimentary Pharmacology & Therapeutics, 2019
- Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2019
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Oral Doses of CJ-12420 (Tegoprazan), A Novel Potassium-Competitive Acid Blocker (P-CAB) in Healthy Male SubjectsClinical Therapeutics, 2017
- The Usefulness of a Structured Questionnaire in the Assessment of Symptomatic Gastroesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1998